Literature DB >> 23400240

Nodular morphea (NM): report of a case of concurrent NM and morphea profunda associated with limited type systemic sclerosis, and overview and definition for NM.

Chika Ohata1, Masako Yasunaga, Daisuke Tsuruta, Norito Ishii, Takahiro Hamada, Teruki Dainichi, Tadashi Karashima, Takekuni Nakama, Takashi Hashimoto.   

Abstract

Morphea consists of various variants, including nodular morphea (NM), keloidal morphea (KM) and morphea profunda (MP). NM and KM are used synonymously. We present a 67-year-old Japanese female, the first case of limited type systemic sclerosis (SSc), developing both NM and MP. The NM and MP lesions on the lower legs were partly continuous, and showed histopathological features of morphea but not of keloid or scar. Pregabalin relieved severe lesional pain. Our literature review of all NM/KM cases indicated that some cases had merely keloid or scar, and, therefore, we first propose to abandon the term KM and use only the term NM for this condition to avoid confusion. We also propose making the diagnosis of NM only in cases showing histopathological features characteristic of SSc or morphea, which should facilitate the establishment of this entity. Our literature review also indicated that NM is closely associated with SSc, while the standard classification for morphea, which does not refer to NM/KM, probably due to ambiguity of this entity, suggests that morphea is rarely associated with SSc. Therefore, NM should be included as a distinct and unique subset in the classification of morphea when the disease entity of NM is established. Establishment of the disease entity of NM may change the general consensus of the rare association of morphea with SSc.

Entities:  

Keywords:  keloidal morphea; limited type systemic sclerosis; morphea profunda; nodular morphea

Mesh:

Year:  2013        PMID: 23400240     DOI: 10.1684/ejd.2012.1893

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  1 in total

1.  Development of keloidal morphea after treatment with cyclosporine in a case of recalcitrant generalized morphea.

Authors:  Sahar Dadkhahfar; Zahra Asadi Kani; Farnaz Araghi; Hamideh Moravvej
Journal:  Clin Case Rep       Date:  2020-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.